Learning Self-Kindness online may ease diabetes distress
NCT ID NCT07051005
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a four-week online self-compassion course can reduce diabetes-related distress, self-criticism, and shame in adults with type 1 or type 2 diabetes. Researchers will enroll 50 participants to see if the program is feasible and acceptable. The course includes weekly videos and exercises based on Compassionate Mind Training.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- online self-compassion training (Compassionate Mind Training)
- What this could lead to
- If it works, this could offer a practical, low-cost way to help people with diabetes feel less distressed and be kinder to themselves.
- What could go wrong
- This is a small feasibility study with only 50 participants, so results may not apply widely. The intervention is self-guided online, so engagement may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years old or older. * Diagnosed with Type 1 or Type 2 diabetes by a clinician in the NHS more than one year ago. * Self-managing theircondition. * Identified by their NHS team as needing support with their mental health due to diabetes-related distress. Exclusion Criteria: * \<18 * Individuals experiencing a current mental health crisis, including severe depression, active suicidal thoughts, or acute psychosis * Unable to read/speak English * Gestational diabetes, Wolfram, and other rarer conditions * Individuals currently experiencing severe substance abuse issues that could interfere with participation in the programme * Individuals without reliable access to the internet and a compatible device (computer or smartphone).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Barts Health NHS Trust
NOT_YET_RECRUITINGLondon, E1 2ES, United Kingdom
-
Betsi Cadwaladr University Health Board (BCUHB)
RECRUITINGBangor, Wales, LL57 2PW, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy aims to free type 1 diabetics from insulin shots
- Muscle-Injected gene therapy aims to help type 1 diabetes control blood sugar
- Can a glucose sensor and family coaching tame type 1 diabetes in toddlers?
- Four pills, one goal: can a new combo tame type 2 diabetes?
- Can a smartphone app help heal diabetic foot wounds?
- Can a handoff plan help teens with chronic illness take charge of their care?